Skip to main content

Overactive Bladder Topic Center

News
05/09/2018
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved a...
05/09/2018
Pharmacy Learning Network
From Pharmacy Learning Network
News
03/26/2018
According to a recent study published in PLoS ONE, idiopathic Parkinson disease may be independently associated with an increased risk of overactive bladder.
According to a recent study published in PLoS ONE, idiopathic Parkinson disease may be independently associated with an increased risk of overactive bladder.
According to a recent study...
03/26/2018
Annals of Long-Term Care
From Annals of Long-Term Care
News
02/23/2018
A selective beta3-adrenoreceptor agonist improves symptoms and quality of life in patients with overactive bladder, a study suggests.
A selective beta3-adrenoreceptor agonist improves symptoms and quality of life in patients with overactive bladder, a study suggests.
A selective beta3-adrenoreceptor...
02/23/2018
Pharmacy Learning Network
From Pharmacy Learning Network
News
09/16/2016
Researchers from Japan assessed the efficacy and safety of fesoterodine vs placebo in elderly females with OAB symptoms, including urgent urinary incontinence and with or without concomitant HT in a post-hoc analysis.
Researchers from Japan assessed the efficacy and safety of fesoterodine vs placebo in elderly females with OAB symptoms, including urgent urinary incontinence and with or without concomitant HT in a post-hoc analysis.
Researchers from Japan assessed...
09/16/2016
Annals of Long-Term Care
From Annals of Long-Term Care
News
06/08/2016
The extended-release formulation of propiverine is "an effective and well-tolerated treatment option" for patients with symptoms of overactive bladder, according to a new study. In addition, the randomized, controlled, multicenter...
The extended-release formulation of propiverine is "an effective and well-tolerated treatment option" for patients with symptoms of overactive bladder, according to a new study. In addition, the randomized, controlled, multicenter...
The extended-release formulation...
06/08/2016
Population Health
From Population Health
News
11/24/2015
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder often involves behavioral strategies such as fluid schedules, timed voiding, and bladder-holding techniques aided by strengthening the pelvic floor. These strategies are not always adequate, however.
Management of overactive bladder...
11/24/2015
Annals of Long-Term Care
From Annals of Long-Term Care
News
12/15/2014
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is prescribed to treat both overactive bladder (OAB) and urinary incontinence due to detrusor overactivity associated with neurologic conditions in adult patients who have had an inadequate response to treatment...
Onabotulinumtoxin-A (BoNT-A) is...
12/15/2014
Annals of Long-Term Care
From Annals of Long-Term Care
News
05/26/2014
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of liposomal onabotulinumtoxinA may be a promising, minimally-invasive approach for treatment of refractory overactive bladder, according to a new study.
Intravesical instillation of...
05/26/2014
Pharmacy Learning Network
From Pharmacy Learning Network
News
04/15/2014
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative to antimuscarinic drugs for older patients with overactive bladder, according to pooled data from several clinical trials.
Mirabegron offers an alternative...
04/15/2014
Pharmacy Learning Network
From Pharmacy Learning Network